Catalent Inc (NYSE:CTLT)
$ 63.48 0 (0%) Market Cap: 11.52 Bil Enterprise Value: 16.13 Bil PE Ratio: 0 PB Ratio: 3.25 GF Score: 80/100

Catalent Inc at Jefferies Healthcare Conference (Virtual) Transcript

Jun 01, 2021 / 02:30PM GMT
Release Date Price: $102.01 (-2.69%)
David Howard Windley
Jefferies LLC, Research Division - MD & Equity Analyst

Hi. Good morning, everybody. Dave Windley with Jefferies health care equity research here again. I cover the contract research and contract manufacturing space. And a leader in that space is Catalent, here to present next. Ticker, CTLT.

The management representatives here to talk to us about Catalent are CEO, John Chiminski; newly appointed CFO, Tom Castellano; and Paul Surdez, VP of IR. So we appreciate your attendance. Thanks so much for being here.

Questions & Answers

David Howard Windley
Jefferies LLC, Research Division - MD & Equity Analyst

I'm going to start, John, with you, just to talk about Catalent's come a long way in a year. Maybe talk about the journey you've been on and things that have kept you busy? And where you see Catalent competitively positioned at this point?

John R. Chiminski
Catalent, Inc. - Chairman & CEO

Yes. So thank you very much, Dave, and great to be here with you. First, I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot